Cargando…

Drug Interaction and Pharmacist

The topic of drug–drug interactions has received a great deal of recent attention from the regulatory, scientific, and health care communities worldwide. Nonsteroidal anti-inflammatory drugs, antibiotics and, in particular, rifampin are common precipitant drugs prescribed in primary care practice. D...

Descripción completa

Detalles Bibliográficos
Autor principal: Ansari, JA
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2964764/
https://www.ncbi.nlm.nih.gov/pubmed/21042495
http://dx.doi.org/10.4103/0975-1483.66807
_version_ 1782189428724203520
author Ansari, JA
author_facet Ansari, JA
author_sort Ansari, JA
collection PubMed
description The topic of drug–drug interactions has received a great deal of recent attention from the regulatory, scientific, and health care communities worldwide. Nonsteroidal anti-inflammatory drugs, antibiotics and, in particular, rifampin are common precipitant drugs prescribed in primary care practice. Drugs with a narrow therapeutic range or low therapeutic index are more likely to be the objects for serious drug interactions. Object drugs in common use include warfarin, fluoroquinolones, antiepileptic drugs, oral contraceptives, cisapride, and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. The pharmacist, along with the prescriber has a duty to ensure that patients are aware of the risk of side effects and a suitable course of action should they occur. With their detailed knowledge of medicine, pharmacists have the ability to relate unexpected symptoms experienced by patients to possible adverse effects of their drug therapy.
format Text
id pubmed-2964764
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Medknow Publications
record_format MEDLINE/PubMed
spelling pubmed-29647642010-11-01 Drug Interaction and Pharmacist Ansari, JA J Young Pharm General Pharmacy The topic of drug–drug interactions has received a great deal of recent attention from the regulatory, scientific, and health care communities worldwide. Nonsteroidal anti-inflammatory drugs, antibiotics and, in particular, rifampin are common precipitant drugs prescribed in primary care practice. Drugs with a narrow therapeutic range or low therapeutic index are more likely to be the objects for serious drug interactions. Object drugs in common use include warfarin, fluoroquinolones, antiepileptic drugs, oral contraceptives, cisapride, and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. The pharmacist, along with the prescriber has a duty to ensure that patients are aware of the risk of side effects and a suitable course of action should they occur. With their detailed knowledge of medicine, pharmacists have the ability to relate unexpected symptoms experienced by patients to possible adverse effects of their drug therapy. Medknow Publications 2010 /pmc/articles/PMC2964764/ /pubmed/21042495 http://dx.doi.org/10.4103/0975-1483.66807 Text en © Journal of Young Pharmacists http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle General Pharmacy
Ansari, JA
Drug Interaction and Pharmacist
title Drug Interaction and Pharmacist
title_full Drug Interaction and Pharmacist
title_fullStr Drug Interaction and Pharmacist
title_full_unstemmed Drug Interaction and Pharmacist
title_short Drug Interaction and Pharmacist
title_sort drug interaction and pharmacist
topic General Pharmacy
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2964764/
https://www.ncbi.nlm.nih.gov/pubmed/21042495
http://dx.doi.org/10.4103/0975-1483.66807
work_keys_str_mv AT ansarija druginteractionandpharmacist